New modalities for treatment of both hypertrophic, atrophic scars and keloids have improved the cosmetic surgeon's approach to the management of this commonly faced problem, which is often of great concern to patients in the postoperative setting. Conventional as well as novel approaches including lasers, silicone pressure dressings, immune modulator therapy and recently developed combination products are covered within the present review. This will give the cosmetic surgeon an in-depth understanding of the wide variety of single modality and multifaceted approaches available for patient management of keloids and hypertrophic scars.
Get full access to this article
View all access options for this article.
References
1.
UricosteSSArndtKADoverJS. Keloids and hypertrophic scars: Review and treatment strategies. Semin Cutan Med Surg. 1999;18:159–171.
2.
PeacockEEJrMaddenJWTrierWC. Biologic basis for the treatment of keloids and hypertrophic scars. South Med J. 1970;63:755–760.
3.
BreastedJN. The Edwin Smith Surgical Papyrus Vol I. Hieroglyphic Transaction and Commentary. Chicago, IL: University of Chicago Press; 1970.
4.
AddisonT. On the keloid of Allbert and untrue keloid. Med Diocochir Tran. 1835;19:19.
5.
AlhadySMSivanantharajahK. Keloids in various races: A review of 175 cases. Plast Reconstr Surg. 1964;44:564–566.
6.
Omo-DareP. Genetic studies on keloids. J Natl Med Assoc. 1975;67:428–430.
7.
BloomD. Heredity of keloids: A review of the literature and report of a family with multiple keloids in five generations. NY State Med J. 1956;56:511–519.
8.
MurrayJCPollachSVPinnelSR. Keloids: A review. J Am Acad Dermatol. 1981;4:461–470.
9.
CastagnoliCPervecciODStellM, The HLA DR beta 11b aligenotype constitutes a risk factor for hypertrophic scarring. Hum Immunol. 1990;24:229–232.
10.
CastagnoliCStellaMMagliacaniG, Anomalous expression of HLA is molecules on keratinocytes and fibroblasts in hypertrophic scars consequent to thermal injury. Clin Exp Immunol. 1990;82:350–354.
11.
RamakrishnanKMThomasKPSundarajanCR. Study of 1000 patients with keloids in South India. Plast Reconstr Surg. 1974;53:276–280.
12.
MuirIFK. On the nature of keloid and hypertrophic scars. Br J Plast Surg. 1990;43:61–69.
13.
BermanBFloresF. The treatment of hypertrophic scars and keloids. Eur J Dermatol. 1998;8:591–596.
14.
BlackburnWRCosmanB. Histologic basis of keloid and hypertrophic scar differentiation. Clinicopathologic correlation. Arch Pathol. 1966;82:65–71.
15.
KischerCWShetlarMR. Collagen and mucopolysaccharides in the hypertrophic scar. Connect Tissue Res. 1974;2:205–213.
16.
KischerCW. The microvessels in hypertrophic scars, keloidal scars and related lesions: A review. J Submicrosc Cytol Pathol. 1992;24:281–296.
17.
DeitchEAWheelamTMRoseM, Hypertrophic burn scars. Analysis of variables. J Trauma. 1983;23:895–898.
18.
KalvakolanuDVBordonEC. An overview of the interferon system. Signal transduction and mechanism of action. Cancer Invest. 1996;14:25–33.
19.
TuanTNichterLS. The molecular boss of keloid and hypertrophic scar formation. Mol Med Today. 1998;4:19–24.
20.
ScottPGDodaGMTredgetEE, Chemical characterization and quantification of proteoglycan in human post-born hypertrophic and mature scars. Clin Sci. 1996;90:417–425.
21.
LinaresHALarsonDL. Proteoglycans and collagenase in hypertrophic scar formation. Plast Reconstr Surg. 1978;62:589–593.
22.
BlockERHallMGDensinMJ, General immunoreactivity in keloid patients. Plast Reconstr Surg. 1979;63:689–695.
23.
IgnotzRAMassagneJ. Transforming growth factor β stimulates the expression of fibronectin and collagen and thru incorporation with the extracellular matrix. J Biol Chem. 1989;264:1860–1869.
24.
GhahanyAShenYJNedeleB, Expanded expression for an RNA insulin-like growth factor - 1 in post burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem. 1995;148:25.
25.
LynchSEColonRRAntoniddesHN. Growth factors in wound healing. Single and synergistic effects a partial thickness porcine skin wound. J Clin Invest. 1989;84:640–646.
26.
EnglishRSShenfeltPD. Keloids and hypertrophic scars. Dermatol Surg. 1999;25:631–638.
HintzBL. Radiotherapy for keloid treatment. J Natl Med Assoc. 1973;65:71–75.
30.
BrookTLBrayMSinclairI, Role of ionizing irradiation in 393 keloids. Int J Radiat Oncol Biol Phys. 1988;15:858–870.
31.
ClaverePBedaneCBohnetblancJM. Post-operative interstitial radiotherapy of keloids by iridium 192: A retrospective study of 46 treated scars. Dermatology. 1997;195:349–352.
32.
ScalafaniAPGordonCMRomoT. Prevention of earlobe keloid recurrence with post-operative corticosteroid injection versus radiation therapy. A randomized prospective study and review of the literature. Dermatol Surg. 1996;22:569–579.
33.
DaviesDM. Scars, hypertrophic scars and keloids. Br Med J. 1985;290:1056–1058.
34.
BausPSLarsonDLStaceyTR, Ultrastructural analysis of pressure-treated human hypertrophied scars. J Trauma. 1976;10:958–967.
35.
Corr-CollinJA. Pressure techniques for the prevention of hypertrophic scar. Clin Plast Surg. 1992:19:733–743.
36.
BermanBFloresF. Comparison of a silicone gel-filled cushion and silicon gel sheeting for the treatment of hypertrophic or keloidal scars. Dermatol Surg. 1999;23:484–486.
37.
WongTWChuHCChenJSCinLJChangLE. Symptomatic keloids in two children—dramatic improvement with silicone cream occlusive dressing. Arch Dermatol. 1995;131:775–777.
38.
GoldMH. Topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. A dermatologic experience. J Dermatol Surg Oncol. 1993;916:912–916.
39.
WongTWChiuHCChangCHLinLJLiuCCChenJS. Silicone cream occlusive dressing—a novel noninvasive regimen in the treatment of keloid. Dermatology. 1996;192:329–333.
40.
KatzBE. Silicone gel sheeting in scar therapy. Cutis. 1995;56:65–67.
41.
RickettsCHMartinLFariaDT, Cytokine MRNA changes during the treatment of hypertrophic scars in the silicone and non-silicone gel dressings. Dermatol Surg. 1996;22:955–959.
42.
AlterTSLewisMBRosenbochA. Laser scar revision: Comparison of CO2 laser vaporization with and without simultaneous pulsed dye laser treatment. Dermatol Surg. 1998;28:1299–1302.
43.
ReikenSRWolfortSFBethiaumeFComptonCTompkinsRGYormushML. Control of hypertrophic scar growth using selective photohemolysis. Lasers Surg Med. 1997;21:7–12.
44.
AbergelPRMerkeCALamTS. Control of tissue metabolism by lasers: Recent developments and future prospects. J Am Acad Dermatol. 1984:11:1142.
45.
ConnellPGHarlandCC. Treatment of keloid scars with pulsed dye laser and intralesional steroid. J Cutan Laser Ther. 2000;2:147–150.
46.
SawcerDLeeHRLoweNJ. Scar revision using laser—review of the literature and an approval. J Dermatol Treat. 1998;9:251–157.
47.
SawcerDLeeHRLoweNJ. Lasers and adjunctive treatments for facial scars: A review. J Cutan Laser Ther. 1999;1:77–83.
48.
WittenbergGA. Prospective study blinded randomized controlled. Study to assess the efficacy of the 585 nm flashlamp pulsed dye laser and silicone sheeting in hypertrophic scar treatment. Arch Dermatol. 1998;135:1049–1053.
49.
SahlWJCleverH. Cutaneous scars Part 1. Int J Dermatol. 1994;33:681–691.
50.
SahlWJCleverH. Cutaneous scars Part II. Int J Dermatol. 1994;33:763–769.
McCoyBJDiegelmannRFCohenIK. In vitro inhibition of cell growth, collagen synthesis and prolylhydroxyase activity by triamcinolone acetanide. Proc Soc Exp Biol Med. 1980;163:216–222.
53.
FriedmanSJButlerDRPittelkowMR. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy. J Am Acad Dermatol. 1988;19:537–541.
54.
RuscianiLRosseGBonoR. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol. 1993;19:529–534.
55.
CeltleyRIBarinRW. The combined use of cryosurgery and intralesional injections of suspension of fluorinated adrenocorticosteroids for reducing keloids and hypertrophic scars. J Dermatol Surg Oncol. 1979;5:54.
56.
GransteinRORookAFlotteTJ, A controlled trial of intralesional recombinant interferon γ in the treatment of keloidal scarring. Arch Dermatol. 1990;126:1295–1302.
57.
EhrlichHPTarverHHuntTK. Inhibition effects of vitamin E on collagen synthesis and wound repair. Ann Surg. 1972;175(2):235–240.
58.
PalmieriBGozziGPalmieriG. Vitamin E, added silicone gel sheet for treatment of hypertrophic scars and keloids. Int J Dermatol. 1993;34:506–509.
59.
de LimpasAMP Janssen. The local treatment of hypertrophic scars and keloids with topical retinoic acid. Br J Dermatol. 1980;103:318–323.
60.
ProcockEE. Pharmacologic control of surface scarring in human beings. Ann Surg. 1981;193:591–597.
61.
TopulBMLewisULBenvenisteK. The use of antihistamine to retard the growth of fibroblasts derived from human skin, scar and keloids. Plast Reconst Surg. 1981;68:227–232.
62.
DolynchokKNZiesmonnMSerlettJM. Topical putresane (fibrostat) in the treatment of hypertrophic scars phase II study. J Plast Reconst Surg. 1982;16:261–266.
63.
SodbergTHallmansTBartholasonL. Treatment of keloids and hypertrophic scars with adhesive zinc tape. Scand J Plast Reconstr Surg. 1982;16:261–266.
64.
BoseJP. Clinical study of a new anti-keloid agent. Ann Plast Surg. 1972;17:235.
65.
DuncanJLThomsonAWMuirLFK. Topical cyclosporine and T lymphocytes in keloid scars. Br J Dermatol. 1991;124:109.
66.
LeeRCPingJM. Calcium antagonists retard extracellular matrix production in connective tissue equivalent. J Surg Res. 1990;49:463–466.
67.
LawrenceWT. Treatment of earlobe keloids with surgery plus adjuvant intralesional verapamil and pressure earrings. Ann Plast Surg. 1996;37:167–169.
68.
WalkerJJ. Ultrasound therapy for keloids. S Afr Med J. 1983;64:270.
69.
HoughiumKBrennerDAChojkierM. d-alpha-tocophenol inhibits collagen alpha I gene expression in cultured human fibroblasts, modulation of constitutive collagen gene expression by lipid peroxidation. J Clin Invest. 1991;6:2230–2235.
70.
FitzpatrickR. Intralesional 5-flurouracil in the treatment of hypertrophic scars and keloids. Dermatol Surg. 1999;25:224–232.
